A detailed history of Fmr LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 579,279 shares of RCKT stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
579,279
Previous 576,667 0.45%
Holding current value
$10.1 Million
Previous $15.5 Million 19.72%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$20.66 - $26.72 $53,963 - $69,792
2,612 Added 0.45%
579,279 $12.5 Million
Q1 2024

May 13, 2024

BUY
$26.16 - $30.74 $1.23 Million - $1.45 Million
47,171 Added 8.91%
576,667 $15.5 Million
Q4 2023

Feb 13, 2024

BUY
$16.78 - $31.94 $3.13 Million - $5.97 Million
186,797 Added 54.51%
529,496 $15.9 Million
Q3 2023

Nov 13, 2023

BUY
$15.07 - $24.05 $1.12 Million - $1.79 Million
74,431 Added 27.75%
342,699 $7.02 Million
Q2 2023

Aug 11, 2023

BUY
$16.59 - $23.6 $581,263 - $826,873
35,037 Added 15.02%
268,268 $5.33 Million
Q1 2023

May 11, 2023

SELL
$15.79 - $22.6 $409,418 - $585,995
-25,929 Reduced 10.01%
233,231 $4 Million
Q4 2022

Feb 13, 2023

BUY
$15.5 - $22.76 $108 - $159
7 Added 0.0%
259,160 $5.07 Million
Q3 2022

Nov 10, 2022

BUY
$12.37 - $18.41 $402,692 - $599,319
32,554 Added 14.37%
259,153 $4.14 Million
Q2 2022

Aug 12, 2022

SELL
$7.96 - $16.64 $358,717 - $749,881
-45,065 Reduced 16.59%
226,599 $3.12 Million
Q1 2022

May 13, 2022

SELL
$13.16 - $23.68 $2.07 Million - $3.73 Million
-157,460 Reduced 36.69%
271,664 $4.31 Million
Q4 2021

Feb 14, 2022

SELL
$21.52 - $36.02 $367,862 - $615,725
-17,094 Reduced 3.83%
429,124 $9.37 Million
Q3 2021

Nov 15, 2021

SELL
$27.42 - $48.97 $3.09 Million - $5.51 Million
-112,618 Reduced 20.15%
446,218 $13.3 Million
Q2 2021

Aug 13, 2021

BUY
$39.41 - $47.25 $22 Million - $26.4 Million
558,836 New
558,836 $24.8 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.32B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.